Incidence of post-thrombotic syndrome and its association with various risk factors in a cohort of Spanish patients after one year of follow-up following acute deep venous thrombosis

Francisco Gabriel; Manuel Labiós; Olga Portolés; Marisa Guillén; Dolores Corella; Francesc Francés; Marcial Martínez; Joaquin Gil; Carmen Saiz

doi:10.1160/TH03-11-0700

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2004; 92(02): 328-336
DOI: 10.1160/TH03-11-0700

Blood Coagulation, Fibrinolysis and Cellular Haemostasis

Schattauer GmbH

Incidence of post-thrombotic syndrome and its association with various risk factors in a cohort of Spanish patients after one year of follow-up following acute deep venous thrombosis

Francisco Gabriel

¹Servicio de Medicina Interna, Hospital Clínico Universitario de Valencia, Valencia, Spain

,

Manuel Labiós

¹Servicio de Medicina Interna, Hospital Clínico Universitario de Valencia, Valencia, Spain

,

Olga Portolés

²Unidad de Epidemiología Genética y Molecular, Departamento de Medicina Preventiva, Facultad de Medicina, Universidad de Valencia, Valencia, Spain

,

Marisa Guillén

²Unidad de Epidemiología Genética y Molecular, Departamento de Medicina Preventiva, Facultad de Medicina, Universidad de Valencia, Valencia, Spain

,

Dolores Corella

²Unidad de Epidemiología Genética y Molecular, Departamento de Medicina Preventiva, Facultad de Medicina, Universidad de Valencia, Valencia, Spain

,

Francesc Francés

²Unidad de Epidemiología Genética y Molecular, Departamento de Medicina Preventiva, Facultad de Medicina, Universidad de Valencia, Valencia, Spain

,

Marcial Martínez

³Departamento de Biopatología Médica, Hospital Universitario La Fe de Valencia, Spain

,

Joaquin Gil

⁴Servicio de Radiodiagnóstico, Hospital Clínico Universitario de Valencia, Spain

,

Carmen Saiz

²Unidad de Epidemiología Genética y Molecular, Departamento de Medicina Preventiva, Facultad de Medicina, Universidad de Valencia, Valencia, Spain

› Author Affiliations

Abstract

Summary

Post-thrombotic syndrome (PTS) is a frequent complication of deep venous thrombosis (DVT). However, neither the incidence nor the moment of PTS appearance are known. The main reason are the criteria used to define PTS, the characteristics of the patients, the study design and the time of follow-up. Our aims were to estimate the early incidence of PTS and its associated factors in a cohort of carefully defined DVT patients. 135 patients with a previous episode of acute idiopathic, phlebographically confirmed DVT, in the lower limbs, were followed up over 12 months. Phlebography was then repeated to determine the appearance of PTS. In addition, we used a validated clinical scale in order to assess the correlation between the clinical and phlebographical diagnosis of the PTS. This scale was applied at 6 and 12 months. The incidence of phlebographically confirmed PTS within the first year was 56.3% for the isolated PTS and 5.9% for PTS plus recurrent DVT, regardless of age, sex, platelet count, INR, or anticoagulation. None of these patients could be diagnosed as having PTS using the clinical validated scale. However, those patients with phlebographically diagnosed PTS had a higher clinical score than those without (P = 0.012). The only factor related to a higher risk of developing a PTS was the localization of the DVT, subjects with both proximal and distal DVT having the highest incidence (P = 0.001). In conclusion, although patients had appropriate anticoagulation, early incidence of PTS was very high, thus making it necessary to develop better diagnostic methods in order to evaluate the PTS impact.

Keywords

Post-thrombotic syndrome - recurrent venous thrombosis - Eco-Doppler - phlebography - validated clinical scale

Full Text

References

References
1 Prandoni P, Lensing A, Cogo A. et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125: 1-7.
2 Jonhnson BF, Manzo RA, Bergelin RO. et al. The site of residual abnormalities in the leg veins in long-term follow-up after deep venous thrombosis and their relationship to the development of the post-thrombotic syndrome. Int Angiol 1996; 15: 14-19.
3 Khan SR, Solymoss S, Lamping DL. et al. Long-term outcomes after deep vein thrombosis: post-phlebitic syndrome and quality of life. J Gen Intern Med 2000; 15: 425-429.
4 Khan SR, Ginsberg JS. The post-thrombotic syndrome: current knowledge, controversies, and directions for future research. Blood Rev 2002; 16: 155-165.
5 Bernardi E, Prandoni P. The post-thrombotic syndrome. Curr Opin in Pulm Med 2000; 06: 335-342.
6 Ziegler S, Schillinger M, Maca TH. et al. Post-thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res 2001; 101: 23-33.
7 Heit JA, Silverstein MD, Mohr DN. et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-463.
8 Rutherford RB, Padberg FT, Comerota AJ. et al. Venous severity scoring: An adjunct to venous outcome assessment. J Vasc Surg 2000; 31: 1307-1312.
9 Huisman MV. Recurrent venous thromboembolism: diagnosis and management. Curr Opin Pulm Med 2000; 06: 330-334.
10 Douketis JD, Crowther MA, Foster GA. et al. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?. Am J Med 2001; 110: 515-519.
11 Vaya A, Mira Y, Martinez M. et al. Biological risk factors for deep vein trombosis. Clin Hemorheol Microcirc 2002; 26: 41-53.
12 Kamida CB, Kistner R, Elkof B. et al. Lower extremity ascending and descending phlebography. En: Gloviczki P, Yao JST. eds. Handbook of venous disorders. 2nd Edition. NY: Arnold; 2001: 132-139.
13 Prandoni P, Villalta S, Bagatella P. et al. The clinical course of deep-vein thrombosis. Prospective long-term follow-up of 528 symptomatic patients. Haematologica 1997; 82: 423-428.
14 Kakkar VV, Gebska M, Kadziola Z. et al. Low-molecular-weight heparin in the acute and long-term treatment of deep vein trombosis. Thromb Haemost 2003; 89: 674-680.
15 Amiral J, Bridey F, Wolf M. et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Haemost 1995; 73: 21-28.
16 Warkentin TE. Heparin-induced skin lesions. Br J Haematol 1996; 92: 494-497.
17 Comp PC. Coumarin-induced skin necrosis. Incidence, mechanisms, management and avoidance. Drug Saf 1993; 08: 128-135.
18 Bauer G. Roentgenological and clinical study of the sequelae of thrombosis. Acta Chir Scand 1942; 86 Suppl: (Suppl. 74) 1-10.
19 Haenen JH, Janssen MCH, van Langen H. et al. The post thrombotic syndrome in relation to venous hemodynamics, as measured by means of duplex scanning and straingauge plethysmography. J Vasc Surg 1999; 29: 1071-1076.
20 Holmström M, Aberg W, Lockner C. et al. Long term clinical follow-up in 256 patients with deep-vein thrombosis initially treated with either unfractionated heparin or dalteparin: a retrospective analysis. Thromb Haemost 1999; 82: 1222-1226.
21 Stradness DE, Langlois Y, Cramer M. et al. Long-term sequelae of acute venous thrombosis. JAMA 1983; 250: 1289-1292.
22 Kakkar VV, Lawrence D. Hemodynamic and clinical assessment after therapy for acute deep vein thrombosis. Am J Surg 1985; 153: 54-63.
23 Monreal M, Martorell A, Callejas JM. et al. Venographic assessment of deep vein thrombosis and risk of developing post-thrombotic síndrome: a prospective study. J Intern Med 1993; 233: 233-238.
24 Brandjes DPM, Buller HR, Heijboer H. Randomised trial of effect of compression stocking in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-762.
25 AbuRahma AF, Stickler DL, Robinson PA. A prospective controlled study of the efficacy of short-term anticoagulation therapy in patients with deep vein thrombosis of the lower extremity. J Vasc Surg 1998; 630-637.
26 Saarinen J, Kallio T, Lehto M. et al. The occurrence of post-thrombotic changes after an acute deep venous thrombosis. J Cardiovasc Surg 2000; 41: 441-446.
27 Ginsberg JS, Hirsh J, Mmath JJ. et al. Prevention and treatment of postphlebitic syndrome. Arch Intern Med 2001; 161: 2105-2109.
28 Villalta S, Bogatella P, Piccioli A. et al. Assessment of validity and reproducibility of a clinical scale for the post-thrombotic syndrome. Haemostasis 1994; 24 Suppl (Suppl. 01) 158a.
29 Lindner DJ, Edwards JM, Phinney ES. et al. Long-term hemodynamic and clinical sequelae of lower extremity DVT. J Vasc Surg 1986; 04: 436-442.
30 Heldal M, Seem E, Snadset PM. et al. DVT: a 7-year follow-up study. J Intern Med 1993; 234: 71-75.
31 Browse NL, Clemenson G, Thomas ML. Is the postphlebitic leg always postphlebitic? Relation between phlebographic appearances of deep-vein thrombosis and late sequelae. BMJ 1980; 281: 1167-1170.
32 Mohr DN, Silverstein MD, Heit JA. et al. The venous stasis syndrome after deep venous thrombosis or pulmonary embolism: a population based study. Mayo Clin Proc 2000; 75: 1249-1256.
33 Lindner DJ, Edwards JM, Phinney ES. et al. Long-term hemodynamic and clinical sequelae of lower extremity deep vein thrombosis. J Vasc Surg 1986; 04: 436-442.
34 Philbrick JT, Becker DM. Calf deep venous thrombosis: a wolf in sheep’s clothing?. Arch Intern Med 1988; 148: 2131-2138.
35 Prandoni P, Lensing A, Prins M. et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med 2002; 137: 955-960.
36 Hirsh J. The optimal duration of anticoagulant therapy for venous thrombosis. N Engl J Med 1995; 332: 1710-1711.
37 Kearon C, Gent M, Hirsh J. et al. A comparison of three months of anticoagulation with extended anticoagulation for first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907.
38 Agnelli G, Prandoni P, Santamaria MG. et al. Three months versus one year of oral anticoagulant therapy for idiopahic deep venous trombosis. N Engl J Med 2001; 345: 165-169.
39 Kearon C. Natural history of venous thromboembolism. Circulation. 2003 107. I-22-I-30.
40 Biguzzi E, Mozzi E, Alatri A. et al. The postthrombotic syndrome in young women: Retrospective evaluation of prognostic factors. Thromb Haemost 1998; 80: 575-577.
41 Ridker P, Goldhaber S, Danielson E. et al. Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med 2003; 348: 1425-1434.
42 Wille-Jorgensen P, Jorgensen T, Anderson M. et al. Postphlebitic syndrome and general surgery: and epidemiologic investigation. Angiology 1991; 42: 397-303.